This compound is a salt form of a benozazepine-based primary amine, typically supplied as a pharmaceutical intermediate. Its structure consists of a tricyclic amine core and a fumaric acid counterion, indicating use in research or manufacturing settings.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 127785-96-0
6-Aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepine (E)-2-butenedioate
Intermediate for epinastine hydrochloride
(alphaR)-alpha-Methyl-3,5-bis(trifluoromethyl)benzenemethanol
Pharmaceutical intermediate
(3S)-4-chloro-3-hydroxybutanenitrile
chiral pharmaceutical intermediate
(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
Empagliflozin intermediate
Ethyl 3-(nitromethyl)hexanoate
pharmaceutical intermediate
(E)-but-2-enedioic acid;6,11-dihydro-5H-benzo[c][1]benzazepin-6-ylmethanamine
IUQYGXGUFNMQGL-WLHGVMLRSA-N
C1C2=CC=CC=C2C(NC3=CC=CC=C31)CN.C(=C/C(=O)O)\C(=O)O
—